'Huge therapeutic potential': University of Sask. researchers make progress on stroke treament
A drug typically used to treat schizophrenia is showing positive signs during early stages of research, bringing down stroke-related swelling in the brain.
The research is being conducted by the researchers from the University of Saskatchewan, Columbia University, and the University of Oxford with help from the Canadian Light Source involves a drug called trifluoperazine (TFP).
TFP is already approved for human use and researchers believe it has the potential to stop swelling in the brain that occurs after a stroke or cerebral injury.
According to a release from the CLS, TFP acts on “doughnut-shaped” water channel proteins called aquaporins, which are in brain cells.
During a stroke, the blood supply to the brain is restricted and prevents cells from receiving enough oxygen, which leads to swelling in the brain as oxygen-starved cells cannot do their usual job of maintaining a balance of fluid, nutrients, and electrolytes.
“Water rushes from the outside through these doughnut-shaped proteins, into the cells that then swell. The build-up of pressure damages the fragile brain tissue, disturbing the flow of electrical signals from the brain to the body,” Dr. Mootaz Salman, Research Scientist in the Department of Physiology, Anatomy, and Genetics at the University of Oxford and the corresponding author on this studysaid in a release.
“Edema, which is swelling due to water or other body fluid accumulation, is the hallmark of stroke and plays a major role in stroke-associated morbidity and mortality.”
The idea is that TFP stops all of this from happening by preventing a signal that would normally cause more aquaporin channels to rise to the surface of brain cells.
“Our novel approach offers new hope for patients with central nervous system injuries and strokes and has a huge therapeutic potential,” Dr. Salman said in the release.
“These findings suggest it could be a good candidate for early phase of human clinical application at a low treatment cost in the near future.”
Dr. Patrice Lindsay, Director of Health Systems Change at the Heart and Stroke Foundation said that any research done to further the medical communities knowledge on strokes is crucial.
“Any new research that’s coming out that shows promise at reducing the impact of stroke, reducing the damage that could be caused, is very exciting, and things we will be watching very closely. We need more research like this,” Dr. Lindsay said.
Dr. Lindsay said international partnerships are important for the field, combining expertise and resources goes a long way to further the study as a community.
“We’re encouraging those international partnerships. Rather than duplicating each other’s work, to work together and leverage, and you can get so much further ahead so much faster. These partnerships are so exciting and a great example for others to follow,” Dr. Lindsay said.
As TFP is already approved for human use, Dr. Lindsay said the process to vigorously test the drug will be a bit quicker, meaning it could potentially be helping patients sooner than if it was a brand new drug.
“We will continue to monitor very closely as this research evolves. When the evidence is substantial enough we can try to quickly move it into practice so it can help as many patients as possible,” Dr. Lindsay told CTV.
CTVNews.ca Top Stories

Federal dental insurance program to be phased in over 2024, benefits to start in May
The new federal dental insurance plan will be phased in gradually over 2024, with the first claims likely to be processed in May, government officials said ahead of a formal announcement scheduled for Monday morning.
'We're trying not to break down': Sask. family desperate to find their loved one last seen in Toronto
The family of 39-year-old Lesley Sparvier has been trying to find and locate her after she left home on foot in Kahkewistahaw First Nation, Sask. on Nov. 28.
Buckingham Palace releases this year’s Christmas card
Buckingham Palace released an image of the Christmas card that King Charles III and Queen Camilla will be sending out this year.
Iowa man arrested in the death of a Nebraska Catholic priest
A man has been arrested in the stabbing death of a Catholic priest who was attacked over the weekend in a church rectory in a small Nebraska community, authorities said.
The Université de Moncton will not be getting a new name
The board of New Brunswick's Universite de Moncton has decided not to change the school's name despite concerns about its connection to a problematic historical figure.
Trump says he won't testify Monday at his New York fraud trial and sees no need to appear again
Donald Trump said Sunday he has decided against testifying for a second time at his New York civil fraud trial, posting on social media that he "VERY SUCCESSFULLY & CONCLUSIVELY" testified last month and saw no need to appear again.
Saskatchewan is a safe space to buy 'sustainable oil,' Scott Moe says
Saskatchewan Premier Scott Moe is working hard to use a global climate change conference as an opportunity to market the province’s non-renewable resources.
LCBO reveals what Ontarians drank the most this year
When it came to what Ontarians brought home during their liquor runs at the LCBO, the company said customers went for options that gave them more bang for their buck.
Al Gore calls UAE hosting COP28 'ridiculous,' slams oil CEO appointed to lead climate talks
Climate advocate and former Vice President Al Gore on Sunday called into question the decision to hold the COP28 climate talks in the United Arab Emirates, a leading producer of the world’s oil.